Cubist Systematic Strategies, LLC Hookipa Pharma Inc. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.27 - $15.0 $12,835 - $151,605	10,107 New	10,107 $14,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $15.0 $12,835 - $151,605	10,107 New	10,107 $14,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $9,629 - $16,724	-7,240 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.26 - $2.52 $11,405 - $22,811	-9,052 Reduced 55.56%	7,240 $17,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $21,669 - $55,242	-9,300 Reduced 36.34%	16,292 $38,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $11,591 - $18,400	1,968 Added 8.33%	25,592 $151,000
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $216,395 - $460,904	23,624 New	23,624 $216,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.